Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775681 · ClinicalTrials.gov registry record · NA
Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT03775681: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT03775681 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03775681, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This trial determines the feasibility of Laryngeal Mask Airway Gastro (Laryngeal Mask Airway) when used on patients who are undergoing endoscopic retrograde cholangiopancreatography for pancreas and bile duct disorders. Laryngeal Mask Airway is a device that helps patients breathe while they are asleep during procedures.
Interventions
- OTHER Interview
- DEVICE Laryngeal Mask Airway
- PROCEDURE Endoscopic Retrograde Cholangiopancreatography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-01-16 |
| Est. Completion | 2020-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03775681
The ClinicalTrials.gov registry entry for NCT03775681 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Interview is the first listed.
NCT03775681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03775681 about?
NCT03775681 is a clinical study titled "Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders". This trial determines the feasibility of Laryngeal Mask Airway Gastro (Laryngeal Mask Airway) when used on patients who are undergoing endoscopic retrograde cholangiopancreatography for pancreas and bile duct disorders. Laryngeal Mask Airway is a device that helps patients breathe while they are asl...
What is the current status of trial NCT03775681?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-01-16. Estimated completion is 2020-04-20.
What interventions are being tested in trial NCT03775681?
The interventions under investigation include: Interview (OTHER), Laryngeal Mask Airway (DEVICE), Endoscopic Retrograde Cholangiopancreatography (PROCEDURE).
Who is sponsoring clinical trial NCT03775681?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.